https://ijrpp.com/ijrpp <p><strong>Welcome to IJRPP,</strong>&nbsp;</p> <p><strong><em>International Journal of Research in Pharmacology &amp; Pharmacotherapeutics</em></strong><strong>&nbsp;(IJRPP) </strong>is a peer-reviewed, Quarterly official international journal allowing access to abstracts<strong>&nbsp;</strong>and<strong>&nbsp;</strong>full-text. The journal is devoted to the promotion of pharmaceutical sciences and related disciplines (Pharmacology, Biopharmaceutics, Pharmacokinetics, Pharmaceutical Medicinal Chemistry, Computational Chemistry &amp; Molecular Drug Design, Pharmacognosy &amp; Phytochemistry, Pharmaceutical Analysis, Pharmacy Practice, Clinical &amp; Hospital Pharmacy, Cell Biology, Genomics &amp; Proteomics, Pharmacogenomics, Bioinformatics including biotechnology, cell &amp; molecular biology, Pharmaceutical biotechnology/microbiology, medical and other life sciences).</p> <p><strong>ISSN</strong>&nbsp;- <strong>International Journal of Research in Pharmacology &amp; Pharmacotherapeutics</strong></p> <p><strong>Online</strong> <strong>: </strong>2278-2656</p> <p><strong>Print</strong> : 2278-2648</p> <p><strong><em>International Journal of Research in Pharmacology &amp; Pharmacotherapeutics</em></strong><strong>&nbsp;</strong>seeks to foster multidisciplinary research and collaboration among scientists, pharmaceutical industries and healthcare sector as well as provide an international forum for the communication and evaluation of data, methods and opinions in pharmaceutical sciences and related disciplines. Although primarily devoted to original research papers, the journal particularly welcomes reviews on current topics of special interest and relevance. All manuscripts will be subjected to rapid peer review. Those of high quality (not previously published and not already under consideration for publication) will be published.</p> <p align="right"><strong>EDITOR.</strong></p> en-US editorijrpp@gmail.com (Prof.Dr.N. Sriram) drnsriram@gmail.com (Sriram Nagarajan) Sat, 29 Jun 2024 07:06:12 +0000 OJS 3.1.2.4 http://blogs.law.harvard.edu/tech/rss 60 https://ijrpp.com/ijrpp/article/view/553 <p>Natural compounds can be a lead compounds, allowing the design and rational planning of new drugs, biomimetic synthesis development and the discovery of new therapeutic properties not yet attributed to known compounds. The present study has made an attempt to evaluate the Phytochemical screening and antifungal activity of <em>Neolamarckia cadamba </em><em>Roxb.</em>&nbsp; leaf extract (NCLE). Antifungal activity of <em>Neolamarckia cadamba</em> was conducted on fungal organism on <em>Aspergillus niger</em>. From phytochemical screening of the crude aqueous, ethanolic &amp; cyclohexane extract of the leaves of showed the presence of Alkaloids, Tannins, Saponins, Steroids and Glycosides. In biological evaluation, the antifungal activities of aqueous, ethanolic &amp; cyclohexane extract of <em>Neolamarckia cadamba</em> under the varying concentration of 25, 50, 75, 100 μg/ml tested against <em>Aspergillus niger</em>. Zone of inhibition of aqueous, ethanolic &amp; cyclohexane extracts were compared with that of standards like Flucanazole in which the aqueous extract of NCLE showed a better antifungal activity next to the standard.&nbsp; The aim of the current research investigation was to perform the extraction, preliminary phytochemical screening and to evaluate the <em>invitro</em> antifungal activity of fruit of <em>Neolamarckia cadamba.</em></p> V.A.N.V. Haritha, Alapati Geethika, Rakam Gopi Krishna, Boddu Harika, Goppa Saraswathi, Gayakwad Rajeshwar Copyright (c) https://ijrpp.com/ijrpp/article/view/553 Thu, 04 Jul 2024 00:00:00 +0000